Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study

BACKGROUND: The evaluation of circulating tumour DNA (ctDNA) from clinical blood samples, liquid biopsy, offers several diagnostic advantages compared with traditional tissue biopsy, such as shorter processing time, reduced patient risk and the opportunity to assess tumour heterogeneity. The histori...

Descripción completa

Detalles Bibliográficos
Autores principales: Walls, G. M., McConnell, L., McAleese, J., Murray, P., Lynch, T. B., Savage, K., Hanna, G. G., de Castro, D. Gonzalez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260736/
https://www.ncbi.nlm.nih.gov/pubmed/32471446
http://dx.doi.org/10.1186/s13014-020-01583-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260736/
https://www.ncbi.nlm.nih.gov/pubmed/32471446
http://dx.doi.org/10.1186/s13014-020-01583-7

Ejemplares similares